Get the Stockscreener App
31.76
1.83%
0.59
Assembly Biosciences Inc stock is traded at $31.76, with a volume of 25,548.
It is up +1.83% in the last 24 hours and up +36.11% over the past month.
Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.
See More
Previous Close:
$31.17
Open:
$30.8
24h Volume:
25,548
Relative Volume:
0.17
Market Cap:
$245.44M
Revenue:
-
Net Income/Loss:
$-61.23M
P/E Ratio:
-2.3492
EPS:
-13.5194
Net Cash Flow:
$22.49M
1W Performance:
+2.75%
1M Performance:
+36.11%
6M Performance:
+123.84%
1Y Performance:
+86.93%
1-Day Range:
$30.80
$32.37
1-Week Range:
$30.00
$32.44
52-Week Range:
$7.75
$32.44
Assembly Biosciences Inc Stock (ASMB) Company Profile
Name
Assembly Biosciences Inc
Sector
Industry
Phone
(833) 409-4583
Address
TWO TOWER PLACE, SOUTH SAN FRANCISCO
Compare ASMB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ASMB
Assembly Biosciences Inc
|
31.99 | 485.01M | 0 | -61.23M | 22.49M | -13.52 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.64 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
634.61 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
427.19 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
843.71 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
185.89 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Assembly Biosciences Inc Stock (ASMB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-24-25 | Initiated | Citizens JMP | Mkt Outperform |
| Aug-18-25 | Resumed | H.C. Wainwright | Buy |
| Mar-25-25 | Initiated | Guggenheim | Buy |
| Sep-20-24 | Upgrade | Jefferies | Hold → Buy |
| Sep-13-21 | Initiated | H.C. Wainwright | Neutral |
| Sep-02-21 | Downgrade | William Blair | Outperform → Mkt Perform |
| Mar-23-21 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Nov-06-20 | Downgrade | Jefferies | Buy → Hold |
| Oct-19-20 | Initiated | Truist | Buy |
| Oct-16-19 | Initiated | Mizuho | Buy |
| Nov-19-18 | Initiated | Leerink Partners | Outperform |
| Oct-08-18 | Upgrade | B. Riley FBR | Neutral → Buy |
| Aug-08-18 | Initiated | Robert W. Baird | Outperform |
| Apr-13-18 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| Jan-05-18 | Initiated | B. Riley FBR, Inc. | Neutral |
| Nov-08-17 | Initiated | Jefferies | Buy |
| May-30-17 | Initiated | Chardan Capital Markets | Buy |
View All
Assembly Biosciences Inc Stock (ASMB) Latest News
Statistical indicators supporting Assembly Biosciences Inc.’s strengthDividend Hike & Daily Chart Pattern Signal Reports - newser.com
How Assembly Biosciences Inc. (V7B) stock compares with tech leadersJuly 2025 Summary & Low Drawdown Trading Strategies - newser.com
What to do if you’re stuck in Assembly Biosciences Inc.Trade Risk Report & Smart Money Movement Alerts - newser.com
Assembly Biosciences Inc. recovery potential after sell offJuly 2025 Reactions & Intraday High Probability Setup Alerts - newser.com
Assembly Biosciences Inc expected to post a loss of 77 cents a shareEarnings Preview - TradingView
Why Assembly Biosciences Inc. stock could rally in 2025July 2025 Decliners & Real-Time Market Sentiment Alerts - newser.com
Assembly Biosciences Inc. stock momentum explainedTrade Risk Assessment & Low Drawdown Investment Ideas - newser.com
Will a bounce in Assembly Biosciences Inc. offer an exitPortfolio Risk Summary & Free Growth Oriented Trading Recommendations - newser.com
Tools to assess Assembly Biosciences Inc.’s risk profilePortfolio Performance Summary & Real-Time Volume Spike Alerts - newser.com
Will Assembly Biosciences Inc. (V7B) stock outperform small cap peersQuarterly Profit Review & Expert Approved Momentum Ideas - newser.com
Is Assembly Biosciences Inc. stock a buy before product launches2025 Earnings Impact & AI Enhanced Trading Signals - newser.com
Is Assembly Biosciences Inc. stock cheap at current valuation2025 Market Trends & Fast Entry Momentum Trade Alerts - newser.com
Will Assembly Biosciences Inc. stock gain from lower inflationBuy Signal & Fast Entry Momentum Alerts - newser.com
Building trade automation scripts for Assembly Biosciences Inc.Quarterly Performance Summary & AI Powered Buy and Sell Recommendations - newser.com
Top chart patterns to watch in Assembly Biosciences Inc.2025 Retail Activity & Free Daily Entry Point Trade Alerts - newser.com
Can Assembly Biosciences Inc. (V7B) stock expand revenue streamsJuly 2025 Selloffs & Breakout Confirmation Trade Signals - newser.com
How to integrate Assembly Biosciences Inc. into portfolio analysis toolsBear Alert & Momentum Based Trading Ideas - newser.com
Will Assembly Biosciences Inc. (V7B) stock benefit from Fed rate cutsEarnings Summary Report & AI Enhanced Trading Alerts - newser.com
Evaluating Assembly Biosciences Inc. with trendline analysisTrade Volume Report & Short-Term High Return Ideas - newser.com
Assembly Biosciences, Inc. (ASMB) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Assembly Biosciences Inc Stock (ASMB) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.68%
0.49%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):